AnalystEdge
Sign inGet started
← All stocks

CRSP — Crispr Therapeutics AG

Median target
$74.5
calls from the last 12 months
Implied return
+49.0%
median target vs. price
Coverage
20 analysts · 24 calls
updated in the last 12 months
Consensus
11/9/0+11 net
Buy / Hold / Sell

Which analysts are behind CRSP's consensus?

See every current rating, price target and the analysts' track records for Crispr Therapeutics AG — plus the full analyst rankings, firm analytics and screener.

Unlock with PremiumSign in

The consensus above reflects 20 analysts with calls on CRSP updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

CRSP elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-10-19InsidersKulkarni SamarthChief Executive OfficerInsider sale47.8K sh @ $49.78$2.4M
2026-10-14InsidersGeorge SimeonDirectorInsider sale14.5K sh @ $49.63 · planned trade$720K
2026-10-14InsidersKulkarni SamarthChief Executive OfficerInsider sale4.1K sh @ $49.26$202K
2026-10-14InsidersKasinger James R.General Counsel and SecrInsider sale1.0K sh @ $49.26$51K
2026-10-06InsidersKasinger James R.General Counsel and SecrInsider sale2.0K sh @ $60.04 · planned trade$119K
2026-09-22InsidersKasinger James R.OfficerInsider sale10.4K sh @ $60.24 · planned trade$626K
2026-09-17InsidersBehbahani AliDirectorInsider sale13.7K sh @ $57.09$781K
2025-04-04ExecutiveKennedy, Robert FSecretarySaleCRISPR Therapeutics AG Common Shares (CRSP)$1,001 - $15,000

More: insider activity · executive branch · trending